I wrote yesterday about some common mistakes that newbie biotech investors often make, such as having knee-jerk negative reactions to earnings "misses" from small developmental companies that have no recurring earnings or revenues anywayI mentioned this happening to Amicus Therapeutics (FOLD) this week -- and on cue, the stock rebounded by nearly ...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.